相似文献
1
Warnings regarding the potential coronavirus disease 2019 (COVID-19) transmission risk: Vaccination is not enough.
Infect Control Hosp Epidemiol. 2022 May;43(5):679-680. doi: 10.1017/ice.2021.63. Epub 2021 Feb 10.
2
Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program-Ontario, Canada, April-May 2021.
Clin Infect Dis. 2022 Mar 23;74(6):1085-1088. doi: 10.1093/cid/ciab617.
3
[Compliance with Vaccination against SARS-CoV-2; Information Transmission Based on Scientific Evidence and Its Difficulty].
Yakugaku Zasshi. 2022;142(6):601-609. doi: 10.1248/yakushi.21-00234-1.
4
Convergence between global BCG vaccination and COVID-19 pandemic.
J Med Virol. 2021 Mar;93(3):1496-1505. doi: 10.1002/jmv.26450. Epub 2020 Sep 29.
5
Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
Emerg Infect Dis. 2022 May;28(5):990-993. doi: 10.3201/eid2805.212418. Epub 2022 Mar 11.
6
[Measurement of Anti-SARS CoV-2 Antibodies following Vaccination: Valuable Monitoring or Irrelevant Tool?].
Anasthesiol Intensivmed Notfallmed Schmerzther. 2022 Apr;57(4):302-306. doi: 10.1055/a-1783-3932. Epub 2022 Apr 21.
7
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
8
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.
Clin Infect Dis. 2022 Apr 9;74(7):1275-1278. doi: 10.1093/cid/ciab643.
9
Cross-protective immunity following coronavirus vaccination and coronavirus infection.
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI151969.
10
COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
Int J Infect Dis. 2022 May;118:167-168. doi: 10.1016/j.ijid.2022.03.008. Epub 2022 Mar 9.
引用本文的文献
1
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Science. 2023 Nov 10;382(6671):eabo7201. doi: 10.1126/science.abo7201.
2
Fundamentals of genomic epidemiology, lessons learned from the coronavirus disease 2019 (COVID-19) pandemic, and new directions.
Antimicrob Steward Healthc Epidemiol. 2021 Dec 7;1(1):e60. doi: 10.1017/ash.2021.222. eCollection 2021.
3
Knowledge and Practice of Health Care Providers Towards Proper Face Mask Utilization to Minimize the Extent of COVID-19 Infection in Amhara Region Referral Hospitals, Ethiopia.
J Multidiscip Healthc. 2021 Jun 28;14:1583-1591. doi: 10.2147/JMDH.S306253. eCollection 2021.
4
Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review.
Innovation (Camb). 2021 May 28;2(2):100116. doi: 10.1016/j.xinn.2021.100116. Epub 2021 May 11.
5
Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak.
J Infect. 2021 Jul;83(1):119-145. doi: 10.1016/j.jinf.2021.04.004. Epub 2021 Apr 11.
Zotero 插件